- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05695157
Clinical Performance and Safety of Suture-TOOL
Clinical Performance and Safety of Suture-TOOL for Abdominal Wound Closure in Men and Women Patients Undergoing Elective Open Abdominal Surgery
The goal of this single arm intervention study is to investigate the safety and performance of a suturing device for closure of the midline incision after open abdominal surgery. The study population consists of 38 patients selected for open abdominal procedures for malignant and benign colorectal disease.
The main question it aims to answer is:
• If the device facilitates a Suture-Length to Wound-Length (SL/WL) ratio of 4:1
Participants laparotomy wound will be closed with the device at the end of the operation and closure related data as closure time and SL/WL ratio will be calculated. The wound will be assessed for infection during the postoperative stay and the chart will be reviewed for wound dehiscence and wound infection.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Lena Toft, RN
- Phone Number: +46(0)424061570
- Email: lena.toft@skane.se
Study Contact Backup
- Name: Marcus Edelhamre, MD Phd
- Phone Number: +46(0)424061555
- Email: marcus.edelhamre@skane.se
Study Locations
-
-
Scania
-
Helsingborg, Scania, Sweden, 25187
- Recruiting
- Helsingborgs Hospital
-
Contact:
- Marcus Edelhamre, MD Phd
- Phone Number: +46(0)424061555
- Email: marcus.edelhamre@skane.se
-
Contact:
- Gabriel Börner, MD
- Phone Number: +46(0)424061276
- Email: gabriel.borner@med.lu.se
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Informed consent: signed written informed consent before inclusion in the investigation
- Sex, age: male and female patients, ≥ 18 years old
Surgery: elective open abdominal surgery for benign or malignant colorectal disease through midline incision.
Anticipated incision length ≥ 12 cm
- Body Mass Index (BMI): 18 - 40 kg/m2 inclusive
- Full comprehension: ability to comprehend the full nature and purpose of the investigation, including possible risks and side effects; ability to co-operate with the Investigator and to comply with the requirements of the entire investigation.
Exclusion Criteria:
- Abdominal Surgery: previous abdominal surgery involving the midline
- Physical findings: clinically significant abnormal physical findings which could interfere with the objectives of the investigation according to the Investigator's opinion; existing midline hernia, cutaneous infection, fistula, psoriasis of abdominal skin; morbidly obese patients
- Pre-operative findings: any pre-operative findings identified by the surgeon/Investigator that may preclude the conduct of the investigation procedures
- Allergy: history of anaphylaxis to drugs or allergic reactions in general, which the Investigator considers could affect the outcome of the investigation
- Diseases: known or identified at surgery disseminated cancer disease; collagen diseases and immune deficiency disorders, according to the Investigator's opinion. Significant history of renal, hepatic, gastrointestinal, cardiovascular, respiratory, skin, haematological, endocrine or neurological diseases that according to the Investigator's opinion may interfere with the aim of the investigation
- Life expectancy: life expectancy less than 1 year
- Medications: any medication that could interfere with the investigation procedures or investigation outcome, according to the Investigator's opinion. Hormonal contraceptives for women are allowed
- Pregnancy and lactation: positive pregnancy test at screening (if applicable); pregnant or breastfeeding women
- Vulnerable subjects: Individuals unable to fully understand all aspects of the investigation that are relevant to the decision to participate, or who could be manipulated or unduly influenced because of a compromised position, expectation of benefits or fear of retaliatory response (ISO 14155:2020 §3.55) will be excluded
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Single arm
Closure of the abdomen after laparotomy with Suture-TOOL.
|
Suture device for fast and standardized closure of the abdominal fascia
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Proportion of patients with Suture length/Wound length (SL/WL) ratio ≥ 4
Time Frame: Measured during laparotomy closure.
|
SL/WL-ratio of patients laparotomy closures will be calculated by measuring (centimeter) and dividing the length of used suture with the length of the laparotomy wound.
|
Measured during laparotomy closure.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Stitch count
Time Frame: Measured during laparotomy closure
|
Number of stitches used for laparotomy closure
|
Measured during laparotomy closure
|
Numbers of sutures used
Time Frame: Counted during laparotomy closure
|
Counted during laparotomy closure
|
|
Incision closure time
Time Frame: Measured during laparotomy closure
|
Time (seconds) from first to last knot during laparotomy closure
|
Measured during laparotomy closure
|
Surgeons´ comfort with device during closure
Time Frame: After laparotomy closure
|
VAS assessment
|
After laparotomy closure
|
Surgeons´ satisfaction with final closure result
Time Frame: After laparotomy closure
|
VAS assessment
|
After laparotomy closure
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Incision not following the midline (exposure of rectus muscle)
Time Frame: During the whole study period of up to 8 months
|
Assessment of midline incision
|
During the whole study period of up to 8 months
|
Thickness of subcutaneous fat
Time Frame: During the whole study period of up to 8 months
|
Measurement of subcutaneous fat (millimeter)
|
During the whole study period of up to 8 months
|
Glove punctures
Time Frame: During the whole study period of up to 8 months
|
Standardized assessment of puncture holes
|
During the whole study period of up to 8 months
|
Re-operation(s) number
Time Frame: 45 days after surgery
|
Chart review
|
45 days after surgery
|
Reasons for unscheduled post-surgery visits
Time Frame: 45 days after surgery
|
Chart review
|
45 days after surgery
|
Type of adverse effects
Time Frame: During the whole study period of up to 8 months
|
All adverse effects derived by spontaneous, unsolicited reports of the subjects or users/handlers, by observation and by routine open questioning will be collected and reported.
|
During the whole study period of up to 8 months
|
Type of adverse device effects
Time Frame: During the whole study period of up to 8 months
|
Identification of adverse device effects
|
During the whole study period of up to 8 months
|
Type of device deficiencies
Time Frame: During the whole study period of up to 8 months
|
Identification of device deficiences
|
During the whole study period of up to 8 months
|
Reasons for device replacement during surgery
Time Frame: During the whole study period of up to 8 months
|
Identification during study period
|
During the whole study period of up to 8 months
|
Patients with wound infections
Time Frame: 45 days after surgery
|
Wound infection postoperatively
|
45 days after surgery
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Marcus Edelhamre, MD Phd, Region Skane
Publications and helpful links
General Publications
- Borner G, Montgomery A. Suture-Tool: A Mechanical Needle Driver for Standardized Wound Closure. World J Surg. 2020 Jan;44(1):95-99. doi: 10.1007/s00268-019-05179-5.
- Borner G, Edelhamre M, Rogmark P, Montgomery A. Suture-TOOL: A suturing device for swift and standardized abdominal aponeurosis closure. Surgery in Practice and Science 2022 11. 100137/doi.org/10.1016
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CRO-21-149
- CIV-22-09-040607 (Other Identifier: Swedish Medical Products Agency)
- SUT 001 (Other Identifier: Suturion AB)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Wound Infection
-
Pulmatrix Inc.TerminatedPost Operative Wound Infection | Postoperative Wound Infection-deepUnited States
-
Carilion ClinicSmith & Nephew, Inc.; DeRoyal Industries, Inc.CompletedImpaired Wound Healing | Postoperative Wound Infection-deepUnited States
-
HITEC-Institute of Medical SciencesCompletedWound Infection | Wound Dehiscence | Wound Surgical | Wound BleedingPakistan
-
PolyPid Ltd.CompletedPostoperative Wound Infection Superficial Incisional | Postoperative Wound Infection Deep Incisional Surgical SiteIsrael
-
Universitat Internacional de CatalunyaHospital de GranollersCompletedSurgical Wound Infection | Postoperative Wound Infection | Postoperative Wound Infection Superficial Incisional | Preventive TherapySpain
-
Children's Healthcare of AtlantaWithdrawnPostoperative Wound InfectionUnited States
-
Military Medical AcademyRecruitingPostoperative Wound Infection Superficial Incisional | Postoperative Wound Infection Deep Incisional Surgical SiteBulgaria
-
PfizerCompletedSurgical Wound Infection | Postoperative Wound Infection
-
Hospital for Special Surgery, New YorkNew York Presbyterian HospitalRecruitingSurgical Wound | Post Operative Wound InfectionUnited States
-
Brentwood Biomedical Research InstituteCompletedPostoperative Wound Infection | Traumatic Wound Infection | Closed Soft Tissue AbscessUnited States
Clinical Trials on Suture-TOOL
-
Montefiore Medical CenterCompletedSurgical Wound Infection | Complications; Cesarean SectionUnited States
-
Hadassah Medical OrganizationUnknownOral Surgical Procedures
-
Stanford UniversityTerminatedNasal Obstruction | Nasal Septum; Deviation, CongenitalUnited States
-
Sun Yat-sen UniversityCompletedSurgery--Complications | Retinoblastoma Bilateral
-
Rutgers UniversityCompleted
-
Università degli Studi dell'InsubriaCompletedSurgical Wound DehiscenceItaly
-
Hospital de MataróCompletedHemorrhoids | Rectal Mucosa ProlapseSpain
-
Washington Hospital Healthcare SystemCompletedKnee Osteoarthritis | Hip Osteoarthritis
-
Yuzuncu Yıl UniversityCompletedImpacted Third Molar ToothTurkey
-
Bezmialem Vakif UniversityCompletedCesarean Section Complications | Wound Heal | Suture Related Complication | Cesarean Wound DisruptionTurkey